FALBERG KATHRYN E 4
4 · Arcus Biosciences, Inc. · Filed Jun 12, 2025
Insider Transaction Report
Form 4
FALBERG KATHRYN E
Director
Transactions
- Award
Stock Option (Rights to Buy)
2025-06-10+38,300→ 38,300 totalExercise: $10.02Exp: 2035-06-09→ Common Stock (38,300 underlying) - Award
Common Stock
2025-06-10+13,300→ 68,600 total
Holdings
- 102,106(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Represents the grant of restricted stock units that vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
- [F2]The option will vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control.